Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Daktronics Inc (DAKT)

19,53

0,07

(0,36%)

Fermé 28 Juin 10:00PM

19,52

-0,01

(-0,05%)

Après les heures de négociation: 12:29AM

Daktronics Inc ([symbol]) Options

DAKT Flux des options

Achats

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
2,50	14,90	19,00	16,74	16,95	0,00	0,00 %	0	1	-
5,00	12,40	16,50	0,00	14,45	0,00	0,00 %	0	0	-
7,50	9,90	14,00	0,00	11,95	0,00	0,00 %	0	0	-
10,00	7,40	11,50	9,47	9,45	0,00	0,00 %	0	10	-
12,50	4,90	9,10	0,00	7,00	0,00	0,00 %	0	0	-
15,00	2,80	5,90	5,79	4,35	0,00	0,00 %	0	33	-
17,50	1,25	2,70	1,25	1,975	-1,00	-44,44 %	10	15	26/6/2026
20,00	0,30	1,00	0,60	0,65	0,00	0,00 %	18	81	26/6/2026
22,50	0,05	0,35	0,05	0,20	-0,15	-75,00 %	1	104	26/6/2026
25,00	0,05	0,15	0,05	0,10	-0,05	-50,00 %	1	5 123	26/6/2026
30,00	0,00	1,15	0,20	0,20	0,00	0,00 %	0	93	-
35,00	0,00	2,15	0,05	0,05	0,00	0,00 %	0	4	-

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Ventes

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
2,50	0,00	0,05	0,00	0,00	0,00	0,00 %	0	0	-
5,00	0,00	2,15	0,18	0,18	0,00	0,00 %	0	1	-
7,50	0,00	2,15	0,00	0,00	0,00	0,00 %	0	0	-
10,00	0,00	2,15	0,00	0,00	0,00	0,00 %	0	0	-
12,50	0,00	0,05	0,05	0,05	0,00	0,00 %	0	140	-
15,00	0,00	2,20	1,50	1,50	0,00	0,00 %	0	1	-
17,50	0,15	2,45	0,15	1,30	-0,27	-64,29 %	1	27	26/6/2026
20,00	0,05	2,35	1,55	1,20	0,00	0,00 %	0	13	-
22,50	2,55	5,30	2,37	3,925	0,00	0,00 %	0	8	-
25,00	3,60	7,70	4,30	5,65	0,00	0,00 %	0	1	-
30,00	8,60	12,60	0,00	10,60	0,00	0,00 %	0	0	-
35,00	13,50	17,60	0,00	15,55	0,00	0,00 %	0	0	-

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SDOTSadot Group Inc	US$ 20,93 (238,67%)	45,35M
PCLAPicoCELA Inc	US$ 6,591 (114,69%)	7,43M
IVFINVO Fertility Inc	US$ 2,44 (96,77%)	115,64M
WSHPWeShop Holdings Ltd	US$ 7,85 (66,67%)	8,28M
INLFINLIF Limited	US$ 0,0462 (54,00%)	2,27B
PSIGPS International Group Ltd	US$ 1,52 (-87,12%)	19,32M
CELZCreative Medical Technology Holdings Inc	US$ 1,184 (-41,67%)	552,45k
LICNLichen International Ltd	US$ 1,02 (-38,92%)	15,6M
BTCTBTC Digital Ltd	US$ 0,7212 (-36,74%)	1,46M
BEGLeverage Shares 2X Long BE Daily ETF	US$ 59,86 (-36,06%)	274,83k
INLFINLIF Limited	US$ 0,0462 (54,00%)	2,27B
GDCGD Culture Group Ltd	US$ 0,01085 (-20,80%)	520,95M
RCTRedCloud Holdings PLC	US$ 0,344 (21,60%)	267,55M
AAPLApple Inc	US$ 283,78 (3,14%)	261,95M
AMZNAmazon.com Inc	US$ 232,69 (2,50%)	248,53M

Eli's Gone

Eli's Gone il y a 5 minutes

halldorson

halldorson il y a 7 minutes

Interesting read -
Wall Street Peer ComparisonsTo gauge where a successful medical device company in this niche can trade, retail investors often look at peer companies targeting localized cancer therapies:Company / Asset ClassClinical StageTypical

Market Cap Visualized Equiv

CatfishHunter

CatfishHunter il y a 7 minutes

Thanks for sharing the details on the Duke/Schaal ELP + I-131 work.

The 2022 Nature Biomedical Engineering paper showed impressive preclinical results in mouse pancreatic cancer models (strong tumor regression, especially combined with nanoparticle paclitaxel). That’s meaningful data

Seminole Red

Seminole Red il y a 9 minutes

PEACHMAN

PEACHMAN il y a 11 minutes

I suggest people read your informative IFUS post again so that it makes sense with my comments

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177740678

YOU stated

If I were the interim CEO of IFUS right now, what would I do? Let's just set

Whalatane

Whalatane il y a 11 minutes

UNCY's UniSource hub .
I suggest you all read up on this B2B plan UNCY is starting to make it really easy for dialysis centers to prescribe , store and bill for OLC .
Its designed to over come a lot of the hurdles , drug co's face launching new drugs into a field dominated by Freseniu

Zadie420

Zadie420 il y a 13 minutes

Exactly eagle8.
I think once we use DCVax-L plus Poly-ICLC, DCVax-D+ and aDC1 treatments in other cancer types we will see tremendous price movement.

porty

porty il y a 16 minutes

Well, I don’t have my shares yet so they are worth nothing. More optimistic now that I might actually get them.

gorbec1

gorbec1 il y a 16 minutes

Let the piggy bank eat .

The excitement builds

OracleWitch66

OracleWitch66 il y a 17 minutes

You as well aqua

OracleWitch66

OracleWitch66 il y a 18 minutes

Hell yeah kj thanks for all your DD much appreciated let's go FITY

Musical Shares

Musical Shares il y a 18 minutes

In over 25 years

It's quite a feature, isn't it?

What seems to always be missing here is that RadioGel was NOT the first thermogel with a radionuclide. It's even in their "prior art" section on their original patent from 1998!

And there have been many oth

eagle8

eagle8 il y a 19 minutes

starric, as usual, thanks for your posts.

The ultimate goal for NWBO is, of course, DCvax-Direct.
With the Kalinski method, aDCs, we won't need many adjuvants anymore.
Then only the companies with the most necessary adjuvants will benefit.
And there aren't that ma

barnstormer

barnstormer il y a 19 minutes

Brazen. Boilerplate noise no, but boilerplate regardless. It's regulatory language the company has to keep repeating until the regulator approves the product. When I noted the language was also written to protect the company from litigation, I was referring to the whole regulatory document. Its car

3331

3331 il y a 20 minutes

$250K IS THE MAGIC NUMBER!
$250,000 profit will get the PPS to COPPER @ P/E = 1,000 (not unusual for stocks turning profitable for the first time and with increasing future growth/revenue/profit projections). This will happen when investors are confident the profit will be achieved, likely

jimr1717

jimr1717 il y a 21 minutes

16 years of the same Ruse. No one is Fooled

Investor2014

Investor2014 il y a 23 minutes

Also carefully read section 2.6.9. Discussion on clinical safety.

That safety discussion is not comparable to a normal approved-drug safety review where risks are identified, quantified, labelled and managed. CHMP found that blarcamesine’s safety package was too small for a large chr

CanadianInvestor1

CanadianInvestor1 il y a 24 minutes

Check video out at 3:55 and 5:11.

CanadianInvestor1

CanadianInvestor1 il y a 25 minutes

New CEO took over 1.5 years ago. Lots of trial data in the last year shows the efficacy of Revyve. Recent video says this is a good time for entry to the US market, due to changes in Medicare rules last year pushing skin subs (competitors to KNBIF) out of business. https://wallstreetanalyzer.com/202

William777

William777 il y a 26 minutes

Drilling down on JB statement, "NutraNomics looks forward to further collaboration announcements with RE Strategies in the near future."
What strategies are coming our way?

SSKILLZ1

SSKILLZ1 il y a 27 minutes

They win a game so the response is to rest lindor, sit aj ewing, and start mark vientos because he is so good defensively at 1b, at 3b he should even be better at this point, wagaman at 1b, baty at 2b, they could get the same result by simply forfeiting the game. And Kodai Senga who should have been

MONTI KING

MONTI KING il y a 27 minutes

I think it’s important to keep in mind that givebux valued VitOrgan/ shop at 39 million almost two years ago.. that was for just 1 piece. VitOrgan decided not to complete the LOI.. and here we are!

The $39 million figure came directly from GivBux’s February 3, 2025, press release an

pos_stock_hoarder

pos_stock_hoarder il y a 29 minutes

Gene Chandler - The Duke of Earl
https://youtu.be/Qa88gqvXJMc

cashclan

cashclan il y a 30 minutes

Probably has nothing

To do with the bullet points.

Liquidity is drying up. No, Liquidity you get a crash. Happened in 1929.

July 4th Independency Day. Without Liquidity the old system has 3 days to critical mass of no return. Then 10 days of f

ProShares Ultra Communic...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.